LFG
CRL icon

Larson Financial Group’s Charles River Laboratories CRL Stock Holding History

Larson Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.7K Sell
166
-7
-4% -$1.3K ﹤0.01% 1653
2025
Q4 		$34.5K Buy
173
+24
+16% +$4.35K ﹤0.01% 1423
2025
Q3 		$23.3K Buy
149
+30
+25% +$4.76K ﹤0.01% 1548
2025
Q2 		$18.1K Buy
119
+42
+55% +$5.6K ﹤0.01% 1533
2025
Q1 		$11.6K Buy
77
+70
+1,000% +$11.7K ﹤0.01% 1577
2024
Q4 		$1.29K Sell
7
-82
-92% -$15.8K ﹤0.01% 1970
2024
Q3 		$17.5K Buy
89
+65
+271% +$13.5K ﹤0.01% 1268
2024
Q2 		$4.96K Buy
24
+16
+200% +$3.63K ﹤0.01% 1450
2024
Q1 		$2.17K Sell
8
-5
-38% -$1.19K ﹤0.01% 1351
2023
Q4 		$3.07K Sell
13
-1
-7% -$197 ﹤0.01% 1289
2023
Q3 		$2.74K Buy
14
+3
+27% +$616 ﹤0.01% 1293
2023
Q2 		$2.31K Hold
11
– – ﹤0.01% 1248
2023
Q1 		$2.22K Hold
11
– – ﹤0.01% 1229
2022
Q4 		$2.4K Hold
11
– – ﹤0.01% 1163
2022
Q3 		$2K Hold
11
– – ﹤0.01% 1103
2022
Q2 		$2K Buy
11
+5
+83% +$1.22K ﹤0.01% 1018
2022
Q1 		$2K Hold
6
– – ﹤0.01% 905
2021
Q4 		$2K Hold
6
– – ﹤0.01% 937
2021
Q3 		$2K Hold
6
– – ﹤0.01% 773
2021
Q2 		$2K Sell
6
-3
-33% -$1K ﹤0.01% 718
2021
Q1 		$3K Hold
9
– – ﹤0.01% 664
2020
Q4 		$2K Hold
9
– – ﹤0.01% 626
2020
Q3 		$2K Buy
9
+6
+200% +$1.25K ﹤0.01% 588
2020
Q2 		$1K Hold
3
– – ﹤0.01% 600
2020
Q1 		$0 Hold
3
– – ﹤0.01% 554
2019
Q4 		$0 Buy
+3
New +$415 ﹤0.01% 589

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Larson Financial Group's CRL Position: Q1 2026 in Review

Larson Financial Group reduced its Charles River Laboratories (CRL) stake by 4% in Q1 2026, selling an estimated $1.3K and leaving 166 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

Larson Financial Group first reported a position in CRL in Q4 2019 and has held it in 26 quarters since. The position peaked at $34.5K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Larson Financial Group held 166 shares of Charles River Laboratories worth $28.7K as of Q1 2026.
  • Larson Financial Group sold 7 Charles River Laboratories shares in Q1 2026, an estimated $1.3K.
  • Charles River Laboratories made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1653 holding.
  • Larson Financial Group first reported a position in Charles River Laboratories in Q4 2019 and has held it in 26 quarters since.
  • Larson Financial Group's Charles River Laboratories position peaked at $34.5K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.